Hester Biosciences Limited
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl… Read more
Hester Biosciences Limited (HESTERBIO) - Total Assets
Latest total assets as of September 2025: ₹6.75 Billion INR
Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) holds total assets worth ₹6.75 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hester Biosciences Limited - Total Assets Trend (2006–2025)
This chart illustrates how Hester Biosciences Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hester Biosciences Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Hester Biosciences Limited's total assets of ₹6.75 Billion consist of 29.9% current assets and 70.1% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 0.9% |
| Accounts Receivable | ₹731.81 Million | 11.2% |
| Inventory | ₹703.77 Million | 10.8% |
| Property, Plant & Equipment | ₹4.09 Billion | 62.7% |
| Intangible Assets | ₹66.57 Million | 1.0% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how Hester Biosciences Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hester Biosciences Limited's current assets represent 29.9% of total assets in 2025, a decrease from 68.6% in 2006.
- Cash Position: Cash and equivalents constituted 0.9% of total assets in 2025, up from 0.8% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is property, plant & equipment at 62.7% of total assets.
Hester Biosciences Limited Competitors by Total Assets
Key competitors of Hester Biosciences Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Hester Biosciences Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Hester Biosciences Limited generates 0.48x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Hester Biosciences Limited generates $ 4.21 in net profit.
Hester Biosciences Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.44 | 1.75 | 2.22 |
| Quick Ratio | 0.98 | 1.22 | 1.44 |
| Cash Ratio | 0.06 | 0.13 | 0.00 |
| Working Capital | ₹623.35 Million | ₹ 953.77 Million | ₹ 963.23 Million |
Hester Biosciences Limited - Advanced Valuation Insights
This section examines the relationship between Hester Biosciences Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.94 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -1.4% |
| Total Assets | ₹6.53 Billion |
| Market Capitalization | $40.94 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hester Biosciences Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Hester Biosciences Limited's assets decreased by 1.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Hester Biosciences Limited (2006–2025)
The table below shows the annual total assets of Hester Biosciences Limited from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹6.53 Billion | -1.35% |
| 2024-03-31 | ₹6.62 Billion | +21.35% |
| 2023-03-31 | ₹5.46 Billion | -2.91% |
| 2022-03-31 | ₹5.62 Billion | +36.76% |
| 2021-03-31 | ₹4.11 Billion | +6.91% |
| 2020-03-31 | ₹3.84 Billion | +28.39% |
| 2019-03-31 | ₹2.99 Billion | +22.70% |
| 2018-03-31 | ₹2.44 Billion | +11.88% |
| 2017-03-31 | ₹2.18 Billion | +18.37% |
| 2016-03-31 | ₹1.84 Billion | +15.37% |
| 2015-03-31 | ₹1.60 Billion | +12.31% |
| 2014-03-31 | ₹1.42 Billion | +14.97% |
| 2013-03-31 | ₹1.24 Billion | +29.63% |
| 2012-03-31 | ₹954.26 Million | +7.11% |
| 2011-03-31 | ₹890.87 Million | +10.00% |
| 2010-03-31 | ₹809.90 Million | +8.68% |
| 2009-03-31 | ₹745.20 Million | +8.56% |
| 2008-03-31 | ₹686.42 Million | +7.52% |
| 2007-03-31 | ₹638.39 Million | +184.17% |
| 2006-03-31 | ₹224.65 Million | -- |